""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_agent_orig"	"response_agent"	"proterm_and_extra"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"baseline_time"	"cohort"	"publication_reference"	"publication_year"	"publication_reference_url"	"subObsID"	"uniqObsID"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"
"role"	""	""	""	"tissue"	"background"	"cell_biomarker"	"background"	"background"	"measured"	"background"	"observed"	"observed"	"pathogen"	"background"	"background"	"vaccine"	"background"	"background"	"background"	"observed"	"background"	"background"	"reference"	"background"	"background"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response agent (original)"	"response agent (cell subset)"	"cell type PRO &extra terms"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"target pathogen"	"vaccine year"	"exposure material"	""	"additional exposure material"	"comparison"	"baseline time"	"cohort"	"publication reference (PMID)"	"publication year"	"Rechtien et al. (2018) Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=28854372'>28854372</a>"	"ID of observation within its submission"	"Uniq ID of observation within submission type"
""	"20180430-hipciof_ctf_28854372"	"2018.04.30"	"hipciof_ctf_4"	"peripheral blood mononuclear cell"	"CD16-negative, CD56-bright natural killer cell"	"CD16-negative, CD56-bright natural killer cell"	""	"cell type frequency"	"positive"	"none"	"3"	"Days"	"Ebola virus"	""	"rVSV-EBOV"	"VO_0004660"	""	"correlated with antibody response at 28d and onward"	"time of vaccination (first dose)"	"adults (18-55)"	"28854372"	"2017"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=28854372"	"1"	"17"
